Free Trial
NASDAQ:VANI

Vivani Medical (VANI) Stock Price, News & Analysis

Vivani Medical logo
$1.02 +0.01 (+0.49%)
Closing price 03:57 PM Eastern
Extended Trading
$1.02 0.00 (-0.49%)
As of 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Vivani Medical Stock (NASDAQ:VANI)

Key Stats

Today's Range
$1.02
$1.04
50-Day Range
$0.96
$1.15
52-Week Range
$0.91
$2.09
Volume
35,814 shs
Average Volume
165,431 shs
Market Capitalization
$60.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00
Consensus Rating
Buy

Company Overview

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Vivani Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

VANI MarketRank™: 

Vivani Medical scored higher than 50% of companies evaluated by MarketBeat, and ranked 524th out of 912 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Vivani Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Vivani Medical has only been the subject of 1 research reports in the past 90 days.

  • Read more about Vivani Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Vivani Medical are expected to remain at ($0.41) per share in the coming year.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vivani Medical is -2.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vivani Medical is -2.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Vivani Medical has a P/B Ratio of 2.50. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Vivani Medical's valuation and earnings.
  • Percentage of Shares Shorted

    1.16% of the float of Vivani Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Vivani Medical has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vivani Medical has recently decreased by 7.02%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Vivani Medical does not currently pay a dividend.

  • Dividend Growth

    Vivani Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.16% of the float of Vivani Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Vivani Medical has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vivani Medical has recently decreased by 7.02%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Vivani Medical this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Vivani Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $108,769.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    44.30% of the stock of Vivani Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 6.78% of the stock of Vivani Medical is held by institutions.

  • Read more about Vivani Medical's insider trading history.
Receive VANI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vivani Medical and its competitors with MarketBeat's FREE daily newsletter.

VANI Stock News Headlines

Trump to redistribute trillions of dollars
Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be laughable if it wasn’t putting so many Americans’ financial futures at severe risk… That’s why, with the 100-day mark of Trump’s second term just days away, it’s time to shine a light on what’s really going on, because if you move your money out of the wrong places and into the right ones before it’s too late… …you could be one of the few who profits from this imminent trillion-dollar reset.
See More Headlines

VANI Stock Analysis - Frequently Asked Questions

Vivani Medical's stock was trading at $1.16 on January 1st, 2025. Since then, VANI stock has decreased by 11.6% and is now trading at $1.0250.
View the best growth stocks for 2025 here
.

Vivani Medical, Inc. (NASDAQ:VANI) issued its earnings results on Monday, March, 31st. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.10) by $0.01.

Shares of VANI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vivani Medical investors own include Second Sight Medical Products (EYES), Enterprise Products Partners (EPD), Nextera Energy Partners (NEP), Altimmune (ALT), Caribou Biosciences (CRBU) and Enbridge (ENB).

Company Calendar

Last Earnings
3/31/2025
Today
5/08/2025
Next Earnings (Estimated)
5/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:VANI
Employees
20
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.00
High Stock Price Target
$4.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+290.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-25,650,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.41 per share
Price / Book
2.50

Miscellaneous

Free Float
32,994,000
Market Cap
$60.73 million
Optionable
Optionable
Beta
2.81
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:VANI) was last updated on 5/8/2025 by MarketBeat.com Staff
From Our Partners